Toronto Star

Health Canada proposes to leave many new GMOs unregulate­d

- LUCY SHARRATT Lucy Sharratt is co-ordinator of the Canadian Biotechnol­ogy Action Network.

Everyone agrees that we need evidence-based decision making. Yet Health Canada is proposing to let companies sell some new geneticall­y engineered (commonly called geneticall­y modified or GM) foods without presenting evidence of their safety to the government.

Health Canada will soon wrap up a public consultati­on on proposed changes to how it implements regulation­s for “novel foods.” If accepted, the changes would mean Canadians could soon be eating some unregulate­d and unreported geneticall­y engineered foods.

As a matter of practice and principle, this should concern all Canadians. The science is clear that the safety of new geneticall­y engineered foods cannot just be assumed. Allowing private corporatio­ns to determine what’s safe abandons public oversight.

Corporatio­ns can already sell GM foods in Canada without labels, and now Health Canada proposes to allow companies to sell some without government safety assessment­s. We cannot accept this shift away from independen­t, government safety reviews of geneticall­y modified organisms (GMOs).

The unregulate­d GMOs in future foods would likely be produced with the new genetic engineerin­g techniques called genome editing or gene editing. These newer techniques are more precise than firstgener­ation genetic engineerin­g, but can create a range of unintended effects in the organism that may impact food safety. Such unexpected effects need to be detected and evaluated. However, Health Canada proposes that if a new GMO has no foreign DNA, then companies themselves can determine if the food is safe or needs a safety review from Health Canada.

Health Canada suggests that companies should look for the more predictabl­e “off-target” effects that can be caused by genome editing, but doesn’t mention looking for the other possible unpredicta­ble effects. For many GMOs with no foreign DNA, all of that checking would be done by product developers, with no government verificati­on.

This is a dangerousl­y narrow approach to the risks posed by genome editing. The process of genome editing is known to result in all kinds of unexpected consequenc­es.

Health Canada would have no access to the science behind these new GMOs.

When it comes to the safety of new GMOs, Health Canada is saying it has confidence in corporatio­ns, but do Canadians? Rather than ensure sound science and transparen­cy, Health Canada is doubling down on corporate science and confidenti­ality. This approach would undermine future claims to “science-based” regulation of GMOs.

Health Canada says it wants regulation to provide “an efficient and predictabl­e pathway to commercial­ization for new products.” The biotechnol­ogy industry is already celebratin­g genome editing as the future of food.

The last day of the consultati­on is May 24.

Newspapers in English

Newspapers from Canada